Sesen Bio, Inc.
(NASDAQ : SESN)

( )
SESN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.18%333.010.0%$4445.04m
BNTXBioNTech SE 2.50%269.420.0%$741.28m
NVAXNovavax, Inc. -14.76%136.8679.4%$606.15m
AMGNAmgen, Inc. 1.39%209.661.4%$553.92m
REGNRegeneron Pharmaceuticals, Inc. 1.92%562.712.7%$439.86m
SNSSSunesis Pharmaceuticals, Inc. 0.98%6.200.7%$433.40m
GILDGilead Sciences, Inc. -0.06%66.861.0%$412.81m
CCXIChemoCentryx, Inc. 3.57%34.852.9%$399.09m
ILMNIllumina, Inc. -0.15%413.453.3%$374.05m
XLRNAcceleron Pharma, Inc. -0.71%172.515.3%$347.84m
VRTXVertex Pharmaceuticals, Inc. 0.04%185.491.9%$269.88m
BIIBBiogen, Inc. -0.58%266.571.7%$242.11m
OCGNOcugen, Inc. 5.40%8.780.0%$185.94m
XENEXenon Pharmaceuticals, Inc. 1.81%30.350.4%$163.28m
CRSPCRISPR Therapeutics AG -1.89%98.370.6%$159.07m

Company Profile

Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.